Treatment of Localized Basal Cell Carcinoma at Low Risk for Recurrence
Clinical Scenario
This protocol addresses patients with localized basal cell carcinoma (BCC) that meets established low-risk criteria. Accurate risk stratification — distinguishing low-risk from high-risk tumors — is the most clinically relevant step in guiding management.
Low-Risk Criteria
A BCC is considered low risk for recurrence when all of the following apply:
- Tumor located in area L (trunk and extremities) and smaller than 20 mm, or in area M (cheeks, forehead, scalp, neck, pretibia) and smaller than 10 mm
- Well-defined borders
- Primary (non-recurrent) tumor
- No immunosuppression
- Not at a site of prior radiation therapy
- Nodular or superficial histologic growth pattern
- No perineural involvement
Treatment Approach — Partial Overview
The recommended treatment for qualifying patients centers on surgical removal with histologic margin assessment. An alternative tissue-destructive technique may be considered in carefully selected anatomic situations. The full algorithm — including the criteria for each option — is available in the complete protocol.
Treatment Goal
Complete tumor removal with histologically negative surgical margins.
References
DOI: 10.1016/j.jaad.2017.10.006
- The most clinically relevant stratification to guide the management of patients with BCC is the differentiation between localized tumors at low versus high risk for recurrence.
- On the basis of the available data, the work group recommends standard excision with a 4-mm margin of uninvolved skin around the tumor and/or biopsy site to a depth of the mid-subcutaneous adipose tissue with histologic margin assessment for low-risk primary BCC.
- C&E may be considered for low-risk tumors in none terminal hair-bearing locations.
- To ensure complete removal with histologically negative margins, standard excision with conventional "bread loaf" histopathologic sectioning must include a margin of clinically normal-appearing skin.
View source ↗